Ruxue Lv

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 1

Top Topics

Small Cell Lung Cancer

Tyrosine Kinase

Top Venues

Expert opinion on drug safety

This page only lists publications with an associated author ORCID identifier.

Publications

Wenjie Li, Ruxue Lv, Wei Wang
Toxicity profiles associated with EGFR-TKIs combined with angiogenesis inhibitors in non-small cell lung cancer: an epidemiological surveillance analysis of the FDA adverse event reporting system. Expert opinion on drug safety (2024)